European Journal of Medical Research

Table 1 Background of the COVID-19 group

From: Retrospective study on the efficacy of monocyte distribution width (MDW) as a screening test for COVID-19

	Age	Male/female	WBC (μL)	CRP (mg/dL)	MDW
Total (N = 80)	49 (15–87)	45/35	4600 (2300–12,500)	1.65 (0.02–25.48)	23.3 (17.2–33.6)
Mild (N = 18)	35 (15–72)	7/11	4600 (2300–7700)	0.65 (0.06–3.62)	23.0 (17.2–29.0)
Moderate I (N = 46)	41 (18–87)	26/20	4600 (2400–9500)	1.64 (0.02–10.42)	22.6 (18.1–33.6)
Moderate II (N = 16)	64.5 (54–82)	12/4	5000 (2500–12,500)	7.81 (0.38–25.48)	26.8 (22.2–33.0)

Data are expressed as the median (range)
WBC, white blood cell; CRP, C-reactive protein; MDW, monocyte distribution width

Back to article page

ISSN: 2047-783X

Contact us

Submission enquiries: jacinth.kennady@springernature.com
General enquiries: info@biomedcentral.com